Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
6th grade Good
|
|
New words:
AstraZeneca, concluded, equal, gain, GlaxoSmithKline, investee, January, MPS, nonrefundable, offset, order, principle, restated, reversal, Supplemental, work
Removed:
acceptable, accredited, addition, adequate, alternative, anticipated, application, applying, assigned, assure, award, Beecham, beginning, book, charge, combination, commercially, commitment, competition, complexity, connection, corporate, dependence, dependent, determine, determined, determining, developing, discount, estimating, exclusive, expire, FASB, fin, fixed, forfeiting, forward, funding, furniture, generated, granted, history, incorporate, institutional, interpretation, introduction, Involving, issued, iv, July, key, landlord, leaving, licensing, literature, manufacture, manufacturing, merged, merger, modify, nature, negotiate, noncompensatory, obligation, occur, office, patent, preferred, previously, price, principally, profit, profitability, proprietary, protection, prove, reduce, reduction, regulatory, release, retain, safe, seek, selected, SmithKline, sublease, successful, tax, technological, term, testing, uncertainty, vested, viable
Filing tables
Filing exhibits
NPSP similar filings
External links